Reviewed,
UniProtKB/Swiss-Prot Q9BUT1 (BDH2_HUMAN)
Last modified
November 3, 2009.
Version 76.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: 3-hydroxybutyrate dehydrogenase type 2 EC=1.1.1.30 Alternative name(s): R-beta-hydroxybutyrate dehydrogenase Dehydrogenase/reductase SDR family member 6 Oxidoreductase UCPA | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 245 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Catalytic activity | (R)-3-hydroxybutanoate + NAD+ = acetoacetate + NADH. |
| Subunit structure | Homotetramer. Ref.9 |
| Subcellular location | |
| Sequence similarities | Belongs to the short-chain dehydrogenases/reductases (SDR) family. |
| Biophysicochemical properties | Kinetic parameters: KM=60 µM for NAD KM=10 mM for R-hydroxybutyrate Vmax=82 nmol/min/mg enzyme (at 30 degrees Celsius) pH dependence: Optimum pH is 7.5-9.0. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cytoplasm |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Ligand | NAD |
| Molecular function | Oxidoreductase |
| PTM | Acetylation Phosphoprotein |
| Technical term | 3D-structure Complete proteome |
| Gene Ontology (GO) | |
| Biological process | fatty acid beta-oxidation Ref.9 Inferred from direct assay. Source: HGNC oxidation reductionInferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | cytoplasm Ref.9 Inferred from direct assay. Source: HGNC |
| Molecular function | 3-hydroxybutyrate dehydrogenase activity Ref.9 Inferred from direct assay. Source: HGNC NAD or NADH binding Ref.9Inferred from direct assay. Source: HGNC |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9BUT1-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9BUT1-2) The sequence of this isoform differs from the canonical sequence as follows: 141-245: VVNRCVYSTT...PVIIDGGWSL → GSVSFRGLRCSYTHIIKSSAFGNRHSRDYNFKY |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 245 | 245 | 3-hydroxybutyrate dehydrogenase type 2 | PRO_0000042580 | |||||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 10 – 37 | 28 | NAD | ||||||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 180 – 184 | 5 | NAD | ||||||||||||||||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 147 | 1 | Proton acceptor By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 58 | 1 | NAD | ||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 144 | 1 | Substrate Probable | ||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 151 | 1 | NAD | ||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 188 | 1 | Substrate Probable | ||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 205 | 1 | Substrate Probable | ||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 48 | 1 | N6-acetyllysine Ref.8 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 132 | 1 | Phosphoserine Ref.6 | ||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 141 – 245 | 105 | VVNRC…GGWSL → GSVSFRGLRCSYTHIIKSSA FGNRHSRDYNFKY in isoform 2. | VSP_015859 | |||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 70 | 1 | N → S: dbSNP rs1054707. Ref.2 Ref.3 Ref.5 | VAR_023602 | |||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 161 | 1 | V → L in AAQ89200. Ref.2 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 230 | 1 | A → T in AAH95414. Ref.5 | ||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 3 – 6 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 8 – 13 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 17 – 28 | 12 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 32 – 38 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 40 – 43 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 44 – 48 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 52 – 56 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 62 – 71 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 76 – 80 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 90 – 92 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 95 – 105 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 107 – 123 | 17 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 126 – 131 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 136 – 138 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 145 – 165 | 21 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 166 – 168 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 170 – 178 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 183 – 191 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 192 – 194 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 195 – 204 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 214 – 225 | 12 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 227 – 229 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 236 – 239 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning." Hu R.-M., Han Z.-G., Song H.-D., Peng Y.-D., Huang Q.-H., Ren S.-X., Gu Y.-J., Huang C.-H., Li Y.-B., Jiang C.-L., Fu G., Zhang Q.-H., Gu B.-W., Dai M., Mao Y.-F., Gao G.-F., Rong R., Ye M. Chen J.-L.Proc. Natl. Acad. Sci. U.S.A. 97:9543-9548(2000) [PubMed: 10931946] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Hypothalamus. |
| [2] | "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment." Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E. Gray A.M.Genome Res. 13:2265-2270(2003) [PubMed: 12975309] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANT SER-70. |
| [3] | "Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)." Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B. Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), VARIANT SER-70. |
| [4] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Ovary. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), VARIANT SER-70. Tissue: Brain and Skin. |
| [6] | "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column." Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y. Anal. Sci. 24:161-166(2008) [PubMed: 18187866] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132, MASS SPECTROMETRY. |
| [7] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [8] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed: 19608861] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-48, MASS SPECTROMETRY. |
| [9] | "Characterization of human DHRS6, an orphan short chain dehydrogenase/reductase enzyme: a novel, cytosolic type 2 R-beta-hydroxybutyrate dehydrogenase." Guo K., Lukacik P., Papagrigoriou E., Meier M., Lee W.H., Adamski J., Oppermann U. J. Biol. Chem. 281:10291-10297(2006) [PubMed: 16380372] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.84 ANGSTROMS) IN COMPLEX WITH NAD, FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, MASS SPECTROMETRY, SUBCELLULAR LOCATION, SUBUNIT. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AF164790 mRNA. Translation: AAF80754.1. AY358841 mRNA. Translation: AAQ89200.1. CR457309 mRNA. Translation: CAG33590.1. AK023323 mRNA. Translation: BAB14526.1. BC037277 mRNA. Translation: AAH37277.1. BC001953 mRNA. Translation: AAH01953.1. BC095414 mRNA. Translation: AAH95414.1. | |||||||||||||
| IPI | IPI00446769. IPI00607799. | ||||||||||||
| RefSeq | NP_064524.3. | ||||||||||||
| UniGene | Hs.124696 | ||||||||||||
3D structure databases | |||||||||||||
| |||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| STRING | Q9BUT1. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q9BUT1. | ||||||||||||
Proteomic databases | |||||||||||||
| PRIDE | Q9BUT1. | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000296424; ENSP00000296424; ENSG00000164039; Homo sapiens. [Genome view] ENST00000432053; ENSP00000409176; ENSG00000164039; Homo sapiens. [Genome view] | ||||||||||||
| GeneID | 56898. | ||||||||||||
| KEGG | hsa:56898. | ||||||||||||
| UCSC | uc003hwz.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 56898. | ||||||||||||
| GeneCards | GC04M104218. | ||||||||||||
| H-InvDB | HIX0004415. | ||||||||||||
| HGNC | HGNC:32389. BDH2. | ||||||||||||
| PharmGKB | PA142672559. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOGENOM | Q9BUT1. | ||||||||||||
| HOVERGEN | Q9BUT1. | ||||||||||||
| OMA | ERIDVLF. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| BRENDA | 1.1.1.30. 247. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q9BUT1. | ||||||||||||
| Bgee | Q9BUT1. | ||||||||||||
| CleanEx | HS_BDH2. | ||||||||||||
| Genevestigator | Q9BUT1. | ||||||||||||
| GermOnline | ENSG00000164039. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR002198. DH_sc/Rdtase_SDR. IPR002347. Glc/ribitol_DH. IPR016040. NAD(P)-bd_dom. [Graphical view] | ||||||||||||
| Gene3D | G3DSA:3.40.50.720. NAD(P)-bd. 1 hit. | ||||||||||||
| PANTHER | PTHR19410. ADH_short_C2. 1 hit. | ||||||||||||
| Pfam | PF00106. adh_short. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR00081. GDHRDH. PR00080. SDRFAMILY. | ||||||||||||
| PROSITE | PS00061. ADH_SHORT. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other Resources | |||||||||||||
| NextBio | 62339. | ||||||||||||
Entry information
| Entry name | BDH2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9BUT1 Secondary accession number(s): Q503A0 Q9NRX8 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 4 Human chromosome 4: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


